

INSERT INTO rman_ruleblocks_citation VALUES (
'rrt_hd_icd',
'Weinhandl ED, Kubisiak KM, Wetmore JB. Low Quality of International
Classification of Diseases, 10th Revision, Procedural Coding System Data
Undermines the Validity of the Standardized Transfusion Ratio: Time to Chart a
New Course? Adv Chronic Kidney Dis. 2019 Jul;26(4):237-249. doi:
10.1053/j.ackd.2019.04.006. PubMed PMID: 31477254.
'
);

INSERT INTO rman_ruleblocks_citation VALUES (
'rrt_pd_icd',
'Iliadou VV, Eleftheriadis N. Response to the Letter from Dr. Vermiglio
Regarding Iliadou and Eleftheriadis (2017): CAPD is Classified in ICD-10 as
H93.25. J Am Acad Audiol. 2018 Mar;29(3):264-265. doi: 10.3766/jaaa.17022. PubMed
PMID: 29488877.'
);

INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_ki_ckd_2012',
'Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: behind the scenes,
need for guidance, and a framework for moving forward. Kidney Int. 2014
Jan;85(1):49-61. doi: 10.1038/ki.2013.444. Epub 2013 Nov 27. Review. PubMed PMID:
24284513.'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_bmc_ehr_2019',
'Horth RZ, Wagstaff S, Jeppson T, Patel V, McClellan J, Bissonette N,
Friedrichs M, Dunn AC. Use of electronic health records from a statewide health
information exchange to support public health surveillance of diabetes and
hypertension. BMC Public Health. 2019 Aug 14;19(1):1106. doi:
10.1186/s12889-019-7367-z. PubMed PMID: 31412826; PubMed Central PMCID:
PMC6694493.'
);
/


INSERT INTO rman_ruleblocks_citation VALUES (
'dm_rxn',
'^https://mor.nlm.nih.gov/RxClass/'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_pcd_2019',
'Van den Bulck SA, Vankrunkelsven P, Goderis G, Broekx L, Dreesen K, Ruijten L,
Mpoukouvalas D, Hermens R. Development of quality indicators for type 2 diabetes,
extractable from the electronic health record of the general physician. A
rand-modified Delphi method. Prim Care Diabetes. 2019 Jun 13. pii:
S1751-9918(19)30108-1. doi: 10.1016/j.pcd.2019.05.002. [Epub ahead of print]
PubMed PMID: 31204263.'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_ada_2018',
'American Diabetes Association. Standards of Medical Care in Diabetes-2018
Abridged for Primary Care Providers. Clin Diabetes. 2018 Jan;36(1):14-37. doi:
10.2337/cd17-0119. PubMed PMID: 29382975; PubMed Central PMCID: PMC5775000.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'dm_dmcare_2014',
'Phillips LS, Ratner RE, Buse JB, Kahn SE. We can change the natural history of
type 2 diabetes. Diabetes Care. 2014 Oct;37(10):2668-76. doi: 10.2337/dc14-0817. 
PubMed PMID: 25249668; PubMed Central PMCID: PMC4170125'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_dmtech_2019',
'Vigersky RA, McMahon C. The Relationship of Hemoglobin A1C to Time-in-Range in
Patients with Diabetes. Diabetes Technol Ther. 2019 Feb;21(2):81-85. doi:
10.1089/dia.2018.0310. Epub 2018 Dec 21. PubMed PMID: 30575414.'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_mja_2012',
'd Emden MC, Shaw JE, Colman PG, Colagiuri S, Twigg SM, Jones GR, et al. 
The role of HbA1c in the diagnosis of diabetes mellitus in Australia. 
The Medical journal of Australia. 2012;197(4):220-1'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_nhmrc_2009',
'Colagiuri S, Davies D, Girgis S, Colagiuri R. National Evidence Based Guideline for Case Detection and Diagnosis of Type 2 Diabetes Canberra: Diabetes Australia and the NHMRC; 2009 [cited 2019 November]'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_tg_2019',
'Therapeutic Guidelines. Diabetes Melbourne: Therapeutic Guidelines Limited; 2019 [cited 2019 November]'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'dm_dm_comp_2018',
'Nanayakkara N, Ranasinha S, Gadowski A, Heritier S, Flack JR, Wischer N, et al. Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. Journal of diabetes and its complications. 2018;32(3):279-90'
);

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_diabetologia_2014',
'Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465-74'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_ada_2016',
'Gunton JE, Cheung NW, Davis TME, Colagiuri S, Zoungas S. Position statement: A new blood glucose management algorithm for type 2 diabetes: Australian Diabetes Society; 2016 [cited 2019 November]'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_bmj_2011',
'Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ (Clinical research ed). 2011;343:d4169'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'dm_nejm_2008',
'Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine. 2008;358(24):2545-59'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'dm_aihw_2019',
'Australian Institute of Health and Welfare. National Key Performance Indicators for Aboriginal and Torres Strait Islander Primary Health Care: Results to June 2018 Canberra: Australian Institute of Health and Welfare,; 2019 [cited 2019 November]'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_dmrr_2018',
'Luo M, Tan KHX, Tan CS, Lim WY, Tai ES, Venkataraman K. Longitudinal trends in
HbA(1c) patterns and association with outcomes: A systematic review. Diabetes
Metab Res Rev. 2018 Sep;34(6):e3015. doi: 10.1002/dmrr.3015. Epub 2018 May 22.
PubMed PMID: 29663623; PubMed Central PMCID: PMC6175395'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'dm_aihwa_atsi_kpi_2018',
'National Key Performance Indicators for Aboriginal and Torres Strait Islander Primary Health Care: Results to June 2018'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'cvd_tg_2019',
'Therapeutic Guidelines. Cardiovascular Melbourne: Therapeutic Guidelines Limited; 2019 [cited 2019 November].'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'cvd_heart_foundation_2012',
'National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Reducing risk in heart disease: an expert guide to clinical practice for secondary prevention of coronary heart disease Melbourne: National Heart Foundation of Australia; 2012 [cited 2019 November]'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'htn_nhf_2016',
'National Heart Foundation of Australia. Guide to management of hypertension in adults - 2016 Melbourne: National Heart Foundation of Australia; 2016 [cited 2019 November]'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'htn_aha_2018',
'Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_mja_2016',
'Gabb GM, Mangoni AA, Anderson CS, Cowley D, Dowden JS, Golledge J, et al. Guideline for the diagnosis and management of hypertension in adults - 2016. The Medical journal of Australia. 2016;205(2):85-9.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_tga_2019',
'Therapeutic Guidelines. Cardiovascular Melbourne: Therapeutic Guidelines Limited; 2019 [cited 2019 November]'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_jnc_2014',
'James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014;311(5):507-20'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_plos_2018',
'Chung S-C, Pujades-Rodriguez M, Duyx B, Denaxas SC, Pasea L, Hingorani A, et al. Time spent at blood pressure target and the risk of death and cardiovascular diseases. PLOS ONE. 2018;13(9):e0202359'
);
/

INSERT INTO rman_ruleblocks_citation VALUES (
'cvra_hlc_2019',
'Tran-Duy A, McDermott R, Knight J, Hua X, Barr ELM, Arabena K, et al. Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians. Heart, Lung and Circulation. 2019'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'cvra_circ_2018',
'Barr EL, Barzi F, Rohit A, Cunningham J, Tatipata S, McDermott R, et al. Abstract 14374: Performance of ACC/AHA Cardiovascular Disease Risk Equations in Indigenous Australians With and Without Diabetes: The CRISP Study Collaboration. Circulation. 2018;138(Suppl_1):A14374-A.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'cvra_nsf_2019',
'National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk: National Stroke Foundation; 2012 [cited 2019 November]'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'cvra_ahj_1991',
'Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. American heart journal. 1991;121(1 Pt 2):293-8'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_rcm_amh_2019',
'Australian Medicines Handbook. Cardiovascular Drugs - Antihypertensives Adelaide: Australian Medicines Handbook; 2019 [cited 2019 November]'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_rcm_aacb_2019',
'Australasian Association of Clinical Biochemists. Reference Intervals - an Overview Sydney: Lab Tests Online Australasia; 2019 [cited 2019 November]'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_rcm_compmethods_2000',
'Persson M, Bohlin J, Eklund P. Development and maintenance of guideline-based 
decision support for pharmacological treatment of hypertension. Comput Methods
Programs Biomed. 2000 Mar;61(3):209-19. PubMed PMID: 10710183'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'htn_rcm_amia_2017',
'Tso GJ, Tu SW, Oshiro C, Martins S, Ashcraft M, Yuen KW, Wang D, Robinson A,
Heidenreich PA, Goldstein MK. Automating Guidelines for Clinical Decision
Support: Knowledge Engineering and Implementation. AMIA Annu Symp Proc. 2017 Feb 
10;2016:1189-1198. eCollection 2016. PubMed PMID: 28269916; PubMed Central PMCID:
PMC5333329'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_ref1',
'Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Summary of Recommendation Statements. Kidney International Supplements. 2013;3(1):5-14.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_ref2',
'Kidney Health Australia. Chronic Kidney Disease (CKD) Management in General Practice 3rd Edition. Melbourne: Kidney Health Australia; 2015. Available from: https://kidney.org.au/cms_uploads/docs/ckdm-in-gp-handbook.pdf'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_cause_ref1',
'Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Summary of Recommendation Statements. Kidney International Supplements. 2013;3(1):5-14.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_cause_ref2',
'Mahmood U, Healy HG, Kark A, Cameron A, Wang Z, Abeysekera R, et al. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service. BMC Nephrol. 2017;18(1):372.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'kfre_ref1',
'Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. Jama. 2011;305(15):1553-9.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'kfre_ref2',
'Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. Jama. 2016;315(2):164-74.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'at_risk_ckd_ref1',
'Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND, et al. KHA-CARI guideline: Early chronic kidney disease: detection, prevention and management. Nephrology (Carlton, Vic). 2013;18(5):340-50.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'at_risk_ckd_ref2',
'Kazancioglu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 2013;3(4):368-71.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'at_risk_ckd_ref3',
'Kidney Health Australia. Chronic Kidney Disease (CKD) Management in General Practice 3rd Edition. Melbourne: Kidney Health Australia; 2015. Available from: https://kidney.org.au/cms_uploads/docs/ckdm-in-gp-handbook.pdf.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_complications_ref1',
'RCPA. Pathology Tests NSW: Royal College of Pathologists of Australasia; 2019 [cited 2020 Feb]. Available from: https://www.rcpa.edu.au/Manuals/RCPA-Manual/Pathology-Tests/.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'ckd_complications_ref2',
'Kidney Health Australia. Chronic Kidney Disease (CKD) Management in General Practice 3rd Edition. Melbourne: Kidney Health Australia; 2015. Available from: https://kidney.org.au/cms_uploads/docs/ckdm-in-gp-handbook.pdf.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'cd_obesity_ref1',
' World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series. 2000;894:i-xii, 1-253.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4610_ref1',
'Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. Jama. 2014;311(24):2518-31.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4620_ref1',
'Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. Jama. 2014;311(24):2518-31.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4620_ref2',
'Janmaat CJ, van Diepen M, van Hagen CC, Rotmans JI, Dekker FW, Dekkers OM. Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis. Clin Epidemiol. 2018;10:613-22.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4410_ref1',
'RCPA. Pathology Tests NSW: Royal College of Pathologists of Australasia; 2019 [cited 2020 Feb]. Available from: https://www.rcpa.edu.au/Manuals/RCPA-Manual/Pathology-Tests/.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4410_ref2',
'Kaminska J, Dymicka-Piekarska V, Tomaszewska J, Matowicka-Karna J, Koper-Lenkiewicz OM. Diagnostic utility of protein to creatinine ratio (P/C ratio) in spot urine sample within routine clinical practice. Critical reviews in clinical laboratory sciences. 2020:1-20.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4420_ref1',
'Isbel NM. Glomerulonephritis--management in general practice. Australian family physician. 2005;34(11):907-13.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4420_ref2',
'Madaio MP, Harrington JT. The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome. Archives of internal medicine. 2001;161(1):25-34.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4420_ref3',
'RCPA. Pathology Tests NSW: Royal College of Pathologists of Australasia; 2019 [cited 2020 Feb]. Available from: https://www.rcpa.edu.au/Manuals/RCPA-Manual/Pathology-Tests/.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4100_ref1',
'Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007;11(2):R31.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4100_ref2',
'Low S, Vathsala A, Murali TM, Pang L, MacLaren G, Ng W-Y, et al. Electronic health records accurately predict renal replacement therapy in acute kidney injury. BMC Nephrology. 2019;20(1):32.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg2610_ref1',
'Gregg LP, Hedayati SS. Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data? Am J Kidney Dis. 2018;72(5):728-44.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg2610_ref2',
'Fraser SDS, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrology. 2015;16(1):193.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4660_ref1',
'Therapeutic Guidelines. Diabetes Melbourne: Therapeutic Guidelines Limited; 2019 [cited 2019 November]. Available from: https%3A%2F%2Ftgldcdp.tg.org.au%2FtopicTeaser%3FguidelinePage%3DDiabetes%26etgAccess%3Dtrue.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4660_ref2',
'Australian Medicines Handbook. Endocrine Drugs Adelaide: Australian Medicines Handbook; 2019 [cited 2019 November]. Available from: https://amhonline.amh.net.au/chapters/endocrine-drugs?menu=vertical.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4660_ref3',
'DeSantis A. Sodium-glucose co-transporter 2 inhibitors for the treatment of hyperglycemia in type 2 diabetes mellitus Waltham, MA: UpToDate Inc; 2019 [cited 2019 November]. Available from: https://www.uptodate.com/contents/sodium-glucose-co-transporter-2-inhibitors-for-the-treatment-of-hyperglycemia-in-type-2-diabetes-mellitus.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4810_ref1',
'Australian Medicines Handbook. Drugs for Anaemias - Erythropoietin Agonists Adelaide: Australian Medicines Handbook; 2019 [cited 2019 November]. Available from: https://amhonline.amh.net.au/chapters/blood-electrolytes/drugs-anaemias/erythropoietin-agonists?menu=vertical.'
);
/
INSERT INTO rman_ruleblocks_citation VALUES (
'tg4810_ref2',
'Jing Z, Wei-jie Y, Nan Z, Yi Z, Ling W. Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysis. PLoS One. 2012;7(8):e43655.');
/

INSERT INTO rman_ruleblocks_citation VALUES (
'cd_obesity_ref2',
'Purnell JQ. Definitions, Classification, and Epidemiology of Obesity. [Updated 2018 Apr 12]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279167/');
/

INSERT INTO rman_ruleblocks_citation VALUES (
'uacr_single_ref2',
'Garg D, Naugler C, Bhella V, Yeasmin F. Chronic kidney disease in type 2 diabetes: Does an abnormal urine albumin-to-creatinine ratio need to be retested? Can Fam Physician. 2018 Oct;64(10):e446-e452. PMID: 30315036; PMCID: PMC6184958.');
/